Conference item icon

Conference item

Tofacitinib improves composite endpoint measures of disease in patients with psoriatic arthritis

Subtitle:
Conference abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1136/annrheumdis-2018-eular.1275

Authors


Helliwell, P More by this author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDORMS
Subgroup:
Botnar Research Centre
ORCID:
0000-0002-4756-663X
Fitzgerald, O More by this author
Soriano, ER More by this author
Expand authors...
Publisher:
BMJ Publishing Group Publisher's website
Volume:
77
Issue:
S2
Pages:
379-380
Publication date:
2018-06-12
DOI:
EISSN:
1468-2060
ISSN:
0003-4967
Pubs id:
pubs:930947
URN:
uri:8a089bda-a133-4d45-a70f-262a222add23
UUID:
uuid:8a089bda-a133-4d45-a70f-262a222add23
Local pid:
pubs:930947

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP